|
WDHD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.73060471403619E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.26819999996175E-06 |
| Normal-vs-Stage2 |
3.293900E-02 |
| Normal-vs-Stage3 |
1.223630E-04 |
| Normal-vs-Stage4 |
2.667600E-02 |
| Stage1-vs-Stage2 |
5.405600E-01 |
| Stage1-vs-Stage3 |
1.647990E-02 |
| Stage1-vs-Stage4 |
5.339600E-01 |
| Stage2-vs-Stage3 |
1.599600E-01 |
| Stage2-vs-Stage4 |
9.185000E-01 |
| Stage3-vs-Stage4 |
2.741800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.23099996652121E-09 |
| Normal-vs-AfricanAmerican |
2.249300E-04 |
| Normal-vs-Asian |
8.065900E-02 |
| Caucasian-vs-AfricanAmerican |
2.335600E-01 |
| Caucasian-vs-Asian |
5.628600E-01 |
| AfricanAmerican-vs-Asian |
1.973600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.63020000118775E-08 |
| Normal-vs-Female |
7.22609999947998E-07 |
| Male-vs-Female |
2.004000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.344580E-03 |
| Normal-vs-Extreme_Weight |
3.419200E-04 |
| Normal-vs-Obese |
1.648280E-04 |
| Normal-vs-Extreme_Obese |
3.184600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.560000E-01 |
| Normal_Weight-vs-Obese |
3.624300E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.600000E-01 |
| Extreme_Weight-vs-Obese |
2.403900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.393000E-01 |
| Obese-vs-Extreme_Obese |
4.806300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.531700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.34350325204014E-11 |
| Normal-vs-Age(61-80Yrs) |
1.57291999999254E-05 |
| Normal-vs-Age(81-100Yrs) |
1.903170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.736380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.462500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.376200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.143950E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.795340E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.622000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.39559996892302E-09 |
| Normal-VS-Type2 PRCC |
1.921380E-03 |
| Normal-VS-KIRP CIMP |
4.437700E-02 |
| Normal-VS-Unclassified PRCC |
3.761300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.037640E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.310300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.827200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.225800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.660100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.149040E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.120200E-03 |
| Normal-vs-N1 |
4.503400E-03 |
| Normal-vs-N2 |
4.205200E-04 |
| N0-vs-N1 |
2.356100E-02 |
| N0-vs-N2 |
4.833600E-01 |
| N1-vs-N2 |
1.034400E-01 |
|
|
